Cargando…

Association between Nrf2 and CDKN2A expression in patients with end-stage renal disease: a pilot study

Patients with end-stage renal disease (ESRD) display phenotypic features of premature biological aging, characterized by disproportionately high morbidity and mortality at a younger age. Nuclear factor erythroid 2-related factor 2 (Nrf2) activity, a master regulator of antioxidative responses, decli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumida, Keiichi, Han, Zhongji, Dashputre, Ankur A., Potukuchi, Praveen K., Kovesdy, Csaba P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485736/ https://www.ncbi.nlm.nih.gov/pubmed/32661200 http://dx.doi.org/10.18632/aging.103685

Ejemplares similares

Association of DNA methylation signatures with premature ageing and cardiovascular death in patients with end-stage kidney disease: a pilot epigenome-wide association study
por: Sumida, Keiichi, et al.
Publicado: (2023)

Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD
por: Dashputre, Ankur A., et al.
Publicado: (2021)

Association of dyskalemias with short-term health care utilization in patients with advanced CKD
por: Dashputre, Ankur A, et al.
Publicado: (2021)

Circulating Microbial Signatures and Cardiovascular Death in Patients With ESRD
por: Sumida, Keiichi, et al.
Publicado: (2021)

Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease
por: Han, Zhongji, et al.
Publicado: (2018)

Abrupt Decline in Kidney Function Precipitating Initiation of Chronic Renal Replacement Therapy
por: Kovesdy, Csaba P., et al.
Publicado: (2017)

Circulating microRNA Profiles for Premature Cardiovascular Death in Patients with Kidney Failure with Replacement Therapy
por: Kuscu, Canan, et al.
Publicado: (2023)

Circulating Microbiota in Cardiometabolic Disease
por: Sumida, Keiichi, et al.
Publicado: (2022)

Constipation in CKD
por: Sumida, Keiichi, et al.
Publicado: (2019)

Association of Uric Acid–Lowering Therapy With Incident Chronic Kidney Disease
por: Hassan, Waleed, et al.
Publicado: (2022)

Statin Therapy Before Transition to End‐Stage Renal Disease With Posttransition Outcomes
por: Soohoo, Melissa, et al.
Publicado: (2019)

Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014–2018
por: Gaipov, Abduzhappar, et al.
Publicado: (2020)

SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation
por: Khan, Md Gulam Musawwir, et al.
Publicado: (2023)

Evidence of chronic kidney disease in veterans with incident diabetes mellitus
por: Gatwood, Justin, et al.
Publicado: (2018)

MIR-491: CDKN2A tumor suppressor co-pilot
por: Moore, Lynette M., et al.
Publicado: (2015)

Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes
por: Gatwood, Justin D., et al.
Publicado: (2018)

Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients
por: Jerotic, Djurdja, et al.
Publicado: (2019)

Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer
por: Deepak Roshan, V G, et al.
Publicado: (2019)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
por: Dai, Wei, et al.
Publicado: (2016)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation
por: Streja, Elani, et al.
Publicado: (2018)

Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes
por: Gatwood, Justin D., et al.
Publicado: (2018)

Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
por: Dashputre, Ankur A., et al.
Publicado: (2020)

Epidermal Proteinase-Activated Receptor-2 Expression is Increased in End-Stage Renal Disease Patients with Pruritus: A Pilot Study
por: Moon, Sung Jin, et al.
Publicado: (2014)

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997)

Spontaneous Cerebrospinal Fluid Rhinorrhea in End Stage Renal Disease
por: Jyothsna, Balachandran P., et al.
Publicado: (2021)

Molecular Genetics and Functional Analysis Implicate CDKN2BAS1-CDKN2B Involvement in POAG Pathogenesis
por: Rathi, Sonika, et al.
Publicado: (2020)

Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
por: Yun, Jae-Seung, et al.
Publicado: (2021)

Real-world evaluation of patiromer utilization and its effects on serum potassium in veterans with end stage kidney disease
por: Pinnell, Derek, et al.
Publicado: (2022)

Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease
por: Tedde, Andrea, et al.
Publicado: (2011)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
por: Arya, Ashutosh Kumar, et al.
Publicado: (2017)

Ezh2 Regulates Activation-Induced CD8(+) T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
por: Chen, Guobing, et al.
Publicado: (2018)

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012)

Protective Role of Nrf2 in Renal Disease
por: Guerrero-Hue, Melania, et al.
Publicado: (2020)

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
por: Tu, Q, et al.
Publicado: (2018)

The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia
por: González-Gil, Celia, et al.
Publicado: (2021)

Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population
por: Cui, Xiaopeng, et al.
Publicado: (2021)

The hypermethylation of the CDKN2A and CHFR promoter region is a key regulatory mechanism of CDKN2A and CHFR expression in esophageal squamous cell carcinoma
por: Mei, Xinyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q7am4ttpgkk9jnpjmlcs35228s